What Researchers Did
Researchers conducted a prospective cohort study to evaluate serum S-100β levels in patients with acute carbon monoxide poisoning as a predictor for delayed neurological sequels and the need for hyperbaric oxygen therapy.
What They Found
Out of 50 patients, 6 developed delayed neurological sequels, and S-100β levels were significantly higher in those with severe poisoning and DNS. A cutoff value of ≥ 0.67 µg/L for S-100β showed 100% sensitivity and 77.3% specificity in predicting DNS, outperforming carboxyhemoglobin and standard hyperbaric oxygen criteria.
What This Means for Canadian Patients
This research suggests that measuring S-100β levels upon admission could help identify carbon monoxide poisoning patients at high risk for delayed neurological issues. This could guide timely and appropriate use of hyperbaric oxygen therapy, potentially improving patient outcomes.
Canadian Relevance
This study was not conducted in Canada and therefore has no direct Canadian connection.
Study Limitations
A limitation of this study is its relatively small sample size of 50 patients.